Skip to content

The effect of topical sodium chlorite gel in treatment of cutaneous leishmaniasis

Comparison of the efficacy of topical sodium chlorite gel with intralesional injection of glucantime to cryotherapy with intralesional injection of glucantime for the improvement of lesions in patients with cutaneous leishmaniasis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190714044200N2
Enrollment
48
Registered
2020-10-02
Start date
2020-09-22
Completion date
Unknown
Last updated
2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous leishmaniasis. Cutaneous leishmaniasis

Interventions

Intervention 1: Intervention group: Topical treatment with sodium chlorite is done in such a way that 0.045% sodium chlorite gel is prepared by the hospital pharmacist and is given to patients in 200

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients over 18 years of age with cutaneous leishmaniasis A maximum of 4 months have passed since the onset of cutaneous leishmaniasis in patients.

Exclusion criteria

Exclusion criteria: Immunodeficient individuals Cutaneous leishmaniasis on the face of patients Pregnancy and lactation Patients with more than 3 lesions of cutaneous leishmaniasis Patients with lesions greater than 5 cm in diameter Patients with concomitant mucosal lesions Patients who have received systemic or topical anti-leishmaniasis medication in the last 4 weeks.

Design outcomes

Primary

MeasureTime frame
Measuring the diameter of cutaneous leishmaniasis lesions in patients. Timepoint: At the beginning of the study, one week later, two weeks later, three weeks later, four weeks after starting treatment. Method of measurement: Measuring ruler.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Miri

Shiraz University of Medical Sciences

miria@sums.ac.ir+98 71 3231 9049

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026